The Role of Radiotherapy in MPNST and the Impact of NF1 Status on Outcomes: Insights From A Multicenter Cohort Study

Breast Cancer

Clinical and patient-reported outcomes after oncoplastic versus conventional breast conserving surgery-a longitudinal, multicenter cohort study

J Natl Cancer Inst

Bargon CA, Mink Van Der Molen DR, Young-Afat DA, Batenburg MCT, Van Dam IE, Baas IO, Ernst MF, Maarse W, Sier MF, Schoenmaeckers EJP, Burgmans JPJ, Bijlsma RM, Siesling S, Rakhorst HA, Mureau MA, Van Der Leij F, Doeksen A, Verkooijen HM, UMBRELLA Study Group

doi: 10.1093/jnci/djae310

Leukemia

Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study

Haematologica

Singh S, Peshin S, Wertheim BC, Larsen A, Chineke I, Sborov DW, Green D, Liedtke M, Okoniewski M, Wazir M, Nadeem O, Schachter LG, DeGraaff D, Vardell VA, Coffey DG, Gowin K

doi: 10.3324/haematol.2024.287158

Lymphoma

Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study

Am J Hematol

Yamshon S, Koff JL, Larson MC, Kahl BS, Casulo C, Lossos IS, Haddadi S, Stanchina M, Chihara D, Ayers A, Habermann TM, Wang Y, Khurana A, Nowakowski GS, Reicks TW, Farooq U, Link BK, Cohen JB, Martin P, Li J, Shewade A, Batlevi CL, Lo-Rossi A, Fox D, Masaquel A, Mun Y, Cerhan JR, Flowers CR, Maurer MJ, Nastoupil LJ

doi: 10.1002/ajh.27630

Lung, Respiratory and Thoracic Cancer

Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study

Lung Cancer

Sugisaka J, Fujimoto D, Tamiya M, Hata A, Matsumoto H, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Kijima T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Saito G, Miura S, Yamaguchi T, Daga H, Sakata S, Yamamoto N, Akamatsu H

doi: 10.1016/j.lungcan.2024.108056

Gynecologic Cancer

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study

Eur J Cancer

Hardie AN, Wenzel HHB, Schnack TH, Van der Aa MA, Jensen PT, Bekkers RLM, Falconer H, Dutch, dANish and sweDish gynaEcoLogIcal ONcology (DANDELION) research group

doi: 10.1016/j.ejca.2025.115664

Further Publications

Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study

Lancet Oncol

Nadauld L, McDonnell CH 3rd, Dilaveri CA, Klein EA, Reid R, Marinac CR, Chung KC, Lopatin M, Fung ET, Schrag D, Patrick DL

doi: 10.1016/S1470-2045(24)00645-4

Gastrointestinal Cancer

Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort

Int J Cancer

van Nassau SCMW, Zwart K, van der Baan FH, Vink GR, Elferink MAG, Snaebjornsson P, May AM, Koopman M, Roodhart JML

doi: 10.1002/ijc.35410

Central Nervous System Tumors

Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter study

Neuro Oncol

Wach J, Basaran AE, Vychopen M, Tihan T, Wostrack M, Butenschoen VM, Meyer B, Siller S, Schmidt NO, Onken J, Vajkoczy P, Santos AN, Rauschenbach L, Dammann P, Sure U, Klingler JH, Doria-Medina R, Beck J, Blaß BI, Gizaw CJ, Hohenhaus R, Krieg S, Alhalabi OT, Klein L, Thomé C, Kögl N, Kunert P, Czernicki T, Pantel T, Middelkamp M, Eicker SO, Kattaa AH, Park DJ, Chang SD, Kilinc F, Czabanka M, Güresir E

doi: 10.1093/neuonc/noaf041